Neudle.com: "striatal necrosis"

Differential
(Click to cross reference)

abortion, spontaneous

abulia

acanthocytosis

aciduria

acquired immunodeficiency syndrome

addiction, heroin

addiction, heroin-neurologic complications with

advances in neurology

adverse drug reaction

affect, flat

agitation

agraphia

Aicardi-Goutieres syndrome

AMPA receptor antibodies

amyotrophic chorea-acanthocytosis

anemia

aneurysm, intracranial

anosmia

anoxia

anti basal ganglia antibodies

anti GQ1b IgG antibody

anti Hu antibody

anti JC virus antibodies

anti-dopamine 2 receptor antibody

antistreptolysin titer

antiviral agents

aortic valve, lesion of

atheromatous branch disease, intracranial

athetosis

attention deficit disorder with hyperactivity

attention span

autoantibodies

autoimmune basal ganglia encephalitis

autoimmune disease

autoimmune GFAP astrocytopathy

autonomic dysfunction

azathioprine

B cell lymphocyte depletion

B cell lymphocytes

bacterial infection

bacterial infection, CNS

ballismus, bilateral

basal ganglia

basal ganglia, calcification of

basal ganglia, degeneration

basal ganglia, hemorrhage

basal ganglia, hemorrhage, bilateral

basal ganglia, infarction

basal ganglia, lesion of

basal ganglia, lesion, bilateral

behavioral disorder

behavioral disorder, acute

biotin deficiency, juvenile form

biotin-responsive basal ganglia disease

blacks

blepharospasm

blindness

blood dyscrasias, neurologic findings with

brain biopsy, false negative

brain biopsy, negative

brain transplantation

calcification, intracranial

calcification, intracranial, rim

candida albicans

carbon monoxide poisoning

carcinoma

carcinoma of lung

cardiac arrest

cardiac arrest and resuscitation

cardiomyopathy

carotid artery occlusion, neck-external and internal art patency with

CAT scan

CAT scan, abnormal

CAT scan, contrast enhanced

CAT scan, emission

CAT scan, emission, abnormal

CAT scan, false negative

catatonia

caudate nucleus

caudate nucleus, atrophy

caudate nucleus, hemorrhage of

caudate nucleus, infarction

caudate nucleus, lesion of

caudate nucleus, lesion of, bilateral

CD4 counts

central nervous system, infection of

central pontine myelinolysis

cerebellar atrophy, primary

cerebellar lesion

cerebral blood flow

cerebral cortex

cerebral cortical atrophy

cerebral embolism

cerebral glucose metabolism

cerebral hypersensitivity, delayed

cerebral infarction

cerebral infarction, subcortical

cerebral ischemia

cerebral palsy

cerebral palsy, associated problems with

cerebral venous thrombosis, deep

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, elevated protein of

cerebrovascular accident

cerebrovascular accident, etiology

cerebrovascular accident, mimics

cerebrovascular accident, secondary prevention

cerebrovascular accident, young adult

ceruloplasmin, serum

chemotherapy, CNS treatment and complications with

chest pain

chest x-ray, abnormal

choreoathetosis, paroxysmal

chromosomal abnormality

Clinical Pathologic Conference(C.P.C.)

collapsin response mediator protein 5 IgG

coma

complications

confusion

congestive heart failure

conjunctival biopsy

controversies in neurology

conus medullaris, lesion of

cop 1

copper metabolism, abnormal

corpus callosotomy

cortical infarction

cough

creatine phosphokinase(CPK)elevated

Creutzfeldt-Jakob disease, genetic

cultured skin fibroblasts

cytomegalovirus infection

demyelinating disease

dentate nuclei, lesion of

dermatomyositis

diabetes mellitus

diabetes mellitus, neurologic manifestations of

diabetic ketoacidosis

diabetic striatopathy

diagnostic criteria

dialysis

diarrhea

differential diagnosis

diplegia, spastic cerebral

disability rating scale, neurological

disability, neurological

disease modifying agents

disulfiram

dopa responsive dystonia

dopamine

dopamine receptor

dopamine receptor, D2

DPPX, antibodies, encephalitis

drooling

drug abuse

drug holiday

drug induced neurologic disorders

dystonia, delayed onset

dystonia, face

dystonia, focal

dystonia, painful

dystonia, post traumatic

dystonia, symptomatic

dystonic reaction, acute

echocardiogram

efficacy

ejection fraction

ejection fraction, abnormal

electroencephalogram

electroencephalogram, abnormalities of

electroencephalogram, periodic complexes

electron microscopy

encephalitis

encephalitis lethargica

encephalitis, autoimmune

encephalitis, brainstem

encephalitis, etiology

encephalitis, human immunodeficiency virus type 1

encephalitis, paraneoplastic

encephalitis, viral

encephalomyelitis

encephalomyelitis, parainfectious

encephalomyelitis, postinfectious

encephalopathy

encephalopathy, acute necrotizing

encephalopathy, acute necrotizing of childhood

encephalopathy, anoxic

encephalopathy, parainfectious

encephalopathy, post anoxic

encephalopathy, progressive

endocarditis

enzyme, defect

eosinophilia

epidemiology of neurology

Epstein-Barr virus, negative

evidence-based research

external capsule

eye movement, disorders of

faciobrachial dystonic seizure

frontal lobe, anatomy and physiology

fumarate

fungal infection, CNS

gadolinium

gait disorder

gamma amino butyric acid receptor antibody

gammaglobulin therapy, intravenous

gaze palsy

gaze palsy, horizontal

genetic neurologic disorders

GFAP gene

GFAP-IgG

globus pallidus

globus pallidus, hemorrhage

globus pallidus, lesion of

globus pallidus, lesion of, bilateral

GLUT1 deficiency syndrome

glutamic acid decarboxylase, antibody

glutaric acidemia

glutaric aciduria

gray matter

Guillain Barre syndrome

gyrus, abnormal

Hallervorden Spatz disease

heavy metal intoxication

hemorrhage, putamenal

hepatic failure

hepatitis

hepatolenticular degeneration(Wilson's disease)

hepatolenticular degeneration, non-Wilsonian

heralding manifestation

herpes simplex encephalitis

Heubner's artery

highly active antiretroviral therapy

hippocampus

hippocampus, hyperintense

Hispanics

Hodgkin's disease

human immunodeficiency virus type 1

Huntington's chorea

Huntington's chorea, akinetic-rigid form

Huntington's chorea, presymptomatic detection of

Huntington's disease, children

hydrocephalus

hyperekplexia

hyperglycemia

hyperglycemia, neurologic dysfunction associated with

hyperglycemia, nonketotic

hypersensitivity reaction

hypertension

hypertonia

hypoglycemia

hypoglycemia, newborn and infant

hypotension, systemic

hypoxia

hypoxia, newborn

hypoxic encephalopathy

iatrogenic neurologic disorders

idiopathic thrombocytopenic purpura

imbalance

immune reconstitution inflammatory syndrome

immunohistochemistry

immunomodulation

immunosuppression

immunosuppressive agents

immunotherapy

in situ hybridization

inborn errors of metabolism

inclusion bodies

incontinence, fecal

infantile bilateral striatal necrosis

intellectual deterioration

intracerebral hemorrhage

intracerebral hemorrhage, bilateral

intracerebral hemorrhage, causes of

intracerebral hemorrhage, differential diagnosis of

intracerebral hemorrhage, lobar

intracerebral hemorrhage, multiple

intracerebral hemorrhage, young adult

intrauterine

iron, brain

Jakob-Creutzfeldt disease

JC virus

Kayser-Fleischer ring

lactic acidemia

lactic dehydrogenase(LDH)

lacunar infarction

laminar necrosis, cortical

laquinimod

lead and the nervous system

lead poisoning

learning disability, in children

leg weakness, bilateral

Leigh's disease

Leigh's disease, adult variety

lenticular nucleus, infarction

lenticular nucleus, lesion of

lenticular nucleus, lesion of, bilateral

lenticulostriate arteries

Lesch-Nyhan syndrome

leucine rich glioma inactivated 1 antibodies

leukemia

leukemia, neurologic findings assoc.with

leukocytosis

leukoencephalopathy

leukopenia

level of consciousness, decreased

limbic encephalitis

listeria monocytogenes

liver disease

liver function enzymes

lymphoma

lymphoma involving CNS

lymphoma, primary of CNS

magnetic susceptibility

malformation, vascular

malformation, vascular, cerebral

malignancy screen

mammillary bodies

marche a petits pas

medication withdrawal

MELAS syndrome

memory, defect of recent

memory, impairment of

meningeal enhancement

mental status, abnormal

mesial temporal lobe

methanol intoxication

microinfarcts

midbrain

midbrain, lesion of

middle cerebral artery territory infarction

mimics

Mini Mental Status Examination

misdiagnosis

mitochondrial disease

mitoxantrone

molecular genetics

monoclonal antibodies

mortality

movement disorder

movement disorder, delayed onset

movement disorder, drug induced

movement disorder, extrapyramidal

MRI

MRI, abnormal

MRI, ADC maps

MRI, CAT scan compared to

MRI, contrast enhanced

MRI, demyelinating disease

MRI, diffusion weighted

MRI, disappearing lesion on

MRI, false negative

MRI, FLAIR

MRI, gradient-echo

MRI, high signal foci on

MRI, high signal intensity of basal ganglia

MRI, hypointense signal foci on

MRI, indications for

MRI, negative

MRI, paramagnetic effect

MRI, punctate pattern

MRI, serial

MRI, spinal cord

MRI, susceptibility weighted

MRI, T1 weighted high signal foci

multiple sclerosis, asymptomatic

multiple sclerosis, children

multiple sclerosis, diagnosis of

multiple sclerosis, differential diagnosis of

multiple sclerosis, disability status scale

multiple sclerosis, disease activity

multiple sclerosis, pathogenesis

multiple sclerosis, plaque

multiple sclerosis, relapsing

multiple sclerosis, treatment of

multiple system atrophy

myasthenia gravis

myasthenia gravis, drug induced

mycoplasma

mycoplasma pneumoniae

mycotoxin

myelinolysis, extrapontine

myelitis

myelitis, autoimmune

myelitis, longitudinal

myelitis, transverse, recurrent

natalizumab, discontinuation

nausea and vomiting

negative

neglect

neoplasm, metastatic to CNS

neoplasm, metastatic to CNS, hemorrhagic

neoplasm, peripheral nerve

neoplasm, primary of CNS

neoplastic angioendotheliosis

neurexin-3 alpha antibodies

neurofibromatosis 1

neurofilament light chain protein

neurologic complications

neurologic complications of, systemic disease

neurologic disease, diagnoses of

neuromyelitis optica (Devic's disease)

neuronal cell surface antigen

neuronal ceroid-lipofuscinosis

neuropathology

neuropathology, brain

neuropathy

neuropathy, iatrogenic

neuropathy, immune

neuropathy, medication induced

neuropathy, motor, multifocal

neuropathy, peripheral, treatment

next-generation sequencing

nonsteroidal anti-inflammatory drug

nutritional deficiency

nystagmus

obsessive-compulsive disorder

occupational neurologic disorders

opportunistic infection

opportunistic infection, CNS

opsoclonus-myoclonus syndrome

optic atrophy

optic nerve, lesion of

optic neuropathy

optic neuropathy, toxic

osmotic demyelination syndrome

Parkinson disease, arteriosclerotic

Parkinson disease, diagnosis

Parkinson disease, differential diagnosis of

Parkinson disease, drug induced

Parkinsonism multiple-system atrophy

Parkinsonism syndrome

pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection

pentoxifylline

periaqueductal lesion

perineural invasion

persistent vegetative state

personality change

photophobia

photosensitivity, skin

pituitary

plasmapheresis

pleocytosis of cerebrospinal fluid

poison, neurologic problems with

poliomyelitis-like illness

polymerase chain reaction

polymerase chain reaction, false negative

polymyositis

polyneuropathy, chronic inflammatory demyelinating

pons, lesion of

posterior leukoencephalopathy syndrome

postpartum

potassium channel antibodies

potassium chlorate

practice guidelines

precipitating factors

pregnancy, neurologic complications in

prevention of neurologic disorders

prion disease

prognosis

progressive multifocal leucoencephalopathy

progressive neurologic disorder

protein 14-3-3, cerebrospinal fluid

psychiatric problems in neurologic disorders

psychological testing

psychosis

ptosis

ptosis, unilateral

pulmonary infiltrates

putamen, lesion of

putamen, lesion of, bilateral

quality of life

radiation therapy, CNS treatment and complications with

radiation therapy, total body

rash

recurrent

remote effect of cancer on the nervous system

renal cell carcinoma

respiratory tract infection

retina, abnormal

retinitis pigmentosa

reversible neurologic disorder

risk-benefit assessment

serologic testing, false negative

seronegative

seropositive

single photon emission computed tomography

skin, biopsy

skin, lesions in neurologic disorders

sleep pathology and physiology

spinal cord, enlargement

spinocerebellar ataxia type 1

splenectomy

spongy degeneration of brain

status marmaratus

steroid

steroid responsive encephalopathy

steroid therapy, CNS treatment and complications with

strangulation

streptococcal infection

striatal encephalitis

striatocapsular infarction

striatonigral degeneration

striatum, lesion of

striatum, lesion of, bilateral

subacute sclerosing panencephalitis(S.S.P.E.)Dawson's disease

symmetric brain lesions

systemic illness

systemic lupus erythematosus

systemic lupus erythematosus, neurologic complications with

T cell lymphocytes

temporal lobe, lesion

temporal lobe, lesion, bilateral

thalamus, lesion of-bilateral

thiamine

thiamine deficiency

third ventricle, wall

torticollis, post traumatic

toxic encephalopathy

toxins, nervous system

trauma

treatment of neurologic disorder

tremor

tuberous sclerosis

tumor necrosis factor

tumor necrosis factor inhibitor

unconsciousness

uremia

uremic encephalopathy

urinary incontinence

urinary tract infection

vaccination, neurologic complications with

Virchow-Robin spaces, dilated

vision, blurred

vision, failure of in childhood

visual acuity

visual acuity, decreased

visual loss

visual loss, progressive

visual loss, slow

vitamin deficiency

walking, difficulty with

weakness

weight loss

Wernicke's encephalopathy

West Nile fever

wheelchair

white matter disease

white matter disease, periventricular

white matter disease, subcortical

workup

xerophthalmia

Showing articles 0 to 50 of 1305 Next >>

Extensive Brainstem and Striatal Involvement in Neuropsychiatric Systemic Lupus Erythematosus
Neurol 102:e209153, Branch, A.,et al, 2024

Inhibition of CD40L with Frexalimab in Multiple Sclerosis
NEJM 390:589-600, 662, Vermersch,P.,et al, 2024

Spectrum of Neuroradiologic Findings Associated with Monogenic Interferonopathies
AJNR 43:2-10, Benjamin, P.,et al, 2022

Wilson Disease Presenting with Catatonia
Neurol 96:e2781-e2782, Patel, R.A. & Bailey, M., 2021

A Young Generalized Dystonia Patient with Globus-Pallidus-Specific Lesion
Ann Neurol 88:637-638, Wu, H.,et al, 2020

A 70-year-old Man with Rapid Stepwise Paraparesis and Sensory Loss
Neurol 94:e651-e655, Krause, M.A.,et al, 2020

MR Imaging of the Brain in Neurologic Wilson Disease
AJNR 40:178-183, Yu, X.-E.,et al, 2019

Simultaneous CMV and Listeria Infection Following Alemtuzumab Treatment for Multiple Sclerosis
Neurol 92:296-298, Pappolla, A.,et al, 2019

A 23-Year-Old Man with Headaches, Confusion, and Lower Extremity Weakness
Neurol 92:863-867, Patel, N.M.,et al, 2019

Distinctive Imaging in a Paucisymptomatic Child with Leukodystrophy
Neruol 91:e1368-e1369, Sharawat, I.K.,et al, 2018

Use of Newer Disease-Modifying Therapies in Pediatric Multiple Sclerosis in the US
Neurol 91:e1778-e1787, Krysko, K.M.,et al, 2018

Antibody-Mediated Encephalitis
NEJM 378:840-851, Dalmau, J.,et al, 2018

Maternal and Fetal Risks of Natalizumab Exposure in Utero
Neurol 90:443-444, Marrie, R.A.,et al, 2018

Acute acalculous cholecystitis
Neurol 90:e1548-e1552, Croteau, D.,et al, 2018

Treatable Bilateral Striatal Lesions Related to Anti-Dopamine 2 Receptor
Neurol 91:98-101, Marques-Matos, C.,et al, 2018

Drug Reaction with Eosinophilia and Systemic Symptoms after Daclizamub Therapy
Neurol 91:e359-e363, Rauer,S.,et al, 2018

Myasthenia Gravis Following Alemtuzumab Therapy for Multiple Sclerosis
Neurol 91:622-624, Midaglia, L.,et al, 2018

Autoimmune Encephalitides: A Broadening Field of Treatable Conditions
Neurologist 22:1-13, Kalman, B., 2017

Natalizumab-Associated PML
Neurol 88:1197-1205, Schwab, N.,et al, 2017

Alemtuzumab CARE-MS I 5-year follow-up
Neurol 89:1107-1116, Havrdova, E.,et al, 2017

Alemtuzumab CARE-MS II 5-year follow-up
Neurol 89:1117-1126, Coles, A.J.,et al, 2017

T2*-Based MR imaging of hyperglycemia-induced hemichorea-hemiballism
J Neuroradiol 44:31-37, Yu, F.,et al, 2017

Clinicopathologic Conference, Biotinthiamine-Responsive Basal Ganglia Disease Due to Mutation SLC19A3
NEJM 377:2376-2385, Case 38-2017, 2017

Superior MRI Outcomes with Alemtuzumab Compared with Subcutaneous Interferon �-1a in MS
Neurol 87:1464-1472, Arnold, D.L.,et al, 2016

Acute Cholecystitis During Treatment with Alemtuzumab in 3 Patients with RRMS
Neurol 87:2380-2381, Pfeuffer, S.,et al, 2016

Acute Hippocampal and Chronic Diffuse White Matter Involvement in Severe Methanol Intoxication
Neurol 87:2382-2383, Takeshige, H.,et al, 2016

Neuroradiologic Patterns and Novel Imaging Findings in Aicardi-Goutieres Syndrome
Neurol 86:28-35, La Piana, R.,et al, 2016

MRI Findings of Biotin-Responsive Basal Ganglia Disease Before and After Treatment
Neurol 86:e71-e72, Saeedan, M.B. & Dogar, M.A., 2016

Fulminant Central Nervous System Nocardiosis in a Patient Treated with Alemtuzumab for Relapsing-Remitting Multiple Sclerosis
JAMA Neurol 73:757-759, Penkert, H.,et al, 2016

Dystonia in Children and Adolescents: A Systematic Review and a New Diagnostic Algorithm
JNNP 86:774-781, Van Egmond, M.E.,et al, 2015

Newer Agents in the Treatment of Multiple Sclerosis
Neurologist 19:104-117, Pawate, S. & Bagnato F., 2015

Swiss Cheese Striatum
Neurohosp doi:1941874415586193, Finelli, P.F., 2015

Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis
NEJM 373:1418-1428, Kappos, L.,et al, 2015

Imaging Findings after Methanol Intoxication (Cohort of 46 Patients)
Neuro Endocrinol Lett 36:101-108, Vaneckova, M.,et al, 2015

Safety and Efficacy of Ofatumumab in Relapsing-Remitting Multiple Sclerosis
Neurol 82:573-581, Sorensen, P.S.,et al, 2014

Striatocapsular Infarction; A Single Institutional Experience
Acta Inform Med 20:106-112, Amin, O.S.M.,et al, 2014

Swiss Cheese Striatum
JAMA Neurol 71:735-741, Burnett, M.S.,et al, 2014

Neuroimaging in Patients with Abnormal Blood Glucose Levels
AJNR 35:833-840, Bathla, G.,et al, 2014

Treatment of Relapsing-Remitting Multiple Sclerosis After 24 Doses of Natalizumab
JAMA Neurol 71:954-960, Clerico, M.,et al, 2014

Mycoplasma Pneumoniae Infection: Neurologic Complications
www.MedLink.com, Oct, Greenlee, J.E., 2013

Daclizumab High-Yield Process in Relapsing-Remitting Multiple Sclerosis (SELECT): A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 381:2167-2175, Gold, R.,et al, 2013

Extensive Striatal, Cortical, and White Matter Brain MRI Abnormalities in Wilson Disease
Neurol 81:1557, Trocello, J.M.,et al, 2013

Clinical Reasoning: A 28-year-old IV Drug User with Bilateral Basal Ganglia and Brainstem Lesions
Neurol 80:e73-e76, Lin, T.,et al, 2013

Daclizumab High-Yield Process in Relapsing-Remitting Multiple Sclerosis (SELECT): A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 381:190-194, Gold, R.,et al, 2013

Severe Relapses under Fingolimod Treatment Prescribed after Natalizumab
Neurol 79:2004-2006,1942, Centonze, D.,et al, 2012

Call It as You See It Evolution of Bilateral Striatal Necrosis
Neurol 78:e123, Coon,E.A. & Patterson,M.C., 2012

Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
NEJM 366:1870-1880,1938, Bloomgren, G.,et al, 2012

Immune Reconstitution Inflammatory Syndrome in Patients With Multiple Sclerosis Following Cessation of Natalizumab Therapy
Arch Neurol 68:186-191, Miravalle,A.,et al, 2011

Fulminant Encephalopathy With Basal Ganglia Hyperintensities in HIV-Infected Drug Users
Neurol 76:787-794, Newsome,S.D.,et al, 2011

Showing articles 0 to 50 of 1305 Next >>